Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
1-7F9 的临床前表征，这是一种新型人类抗 KIR 受体治疗性抗体，可增强自然杀伤细胞介导的肿瘤细胞杀伤作用
期刊:Blood
影响因子:21
doi:10.1182/blood-2009-02-206532
Francois Romagné, Pascale André, Pieter Spee, Stefan Zahn, Nicolas Anfossi, Laurent Gauthier, Marusca Capanni, Loredana Ruggeri, Don M Benson Jr, Bradley W Blaser, Mariella Della Chiesa, Alessandro Moretta, Eric Vivier, Michael A Caligiuri, Andrea Velardi, Nicolai Wagtmann
